PUBLISHER: Grand View Research | PRODUCT CODE: 2152440
PUBLISHER: Grand View Research | PRODUCT CODE: 2152440
The global endoscopy operative devices market size was valued at USD 11.4 billion in 2025 and is projected to grow from USD 12.0 billion in 2026 to USD 17.2 billion in 2033, at a CAGR of 5.3% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 40.0% in 2025. The increasing prevalence of chronic diseases, particularly among the elderly population, is a major driver of market growth. Conditions such as gallstones, liver abscesses, pelvic abscesses, intestinal perforation, and endometriosis often require endoscopic intervention, resulting in a growing demand for endoscopy operative devices.
The shift to minimally invasive procedures is another key factor accelerating market growth. Endoscopic procedures offer numerous advantages, including reduced post-operative pain and complications, faster recovery, lighter anesthesia, and shorter hospital stays. This trend is expected to continue as patients and healthcare providers increasingly recognize the benefits of minimally invasive procedures. Technological advancements in endoscopic imaging and visualization systems are enhancing procedural precision, improving diagnostic accuracy, and enabling more effective therapeutic interventions. For instance, in October 2025, Fujifilm announced the launch of its next-generation ELUXEO 8000 Endoscopic Imaging System, featuring 4K resolution, enhanced LED multi-light technology, and a new Amber Red Color Imaging (ACI) mode to improve visualization during diagnostic and therapeutic endoscopic procedures. This launch reflects the industry's continued focus on advancing endoscopic technologies that enhance clinical outcomes, improve procedural efficiency, and support the growing adoption of minimally invasive surgery.
Favorable demographic trends in the global population are also contributing to market growth. According to the UN, by 2050, the global population aged 60 and above is projected to double, representing approximately 22.0% of the total population. This demographic shift is expected to drive demand for endoscopic procedures as the elderly population is more prone to chronic diseases requiring endoscopic intervention. Furthermore, growing awareness of the benefits of minimally invasive procedures is driving the rising demand for endoscopy.
The increasing demand for gastrointestinal endoscopy is also expected to drive market growth. This trend is driven by the rising prevalence of gastrointestinal disorders globally. The growing number of healthcare centers and the upgrading of healthcare infrastructure in developed and emerging economies are also driving demand for endoscopes and operative devices. Moreover, manufacturers are increasingly integrating artificial intelligence into endoscopy platforms to improve lesion detection and clinical decision-making. For instance, in September 2025, Olympus announced the commercial launch of its OLYSENSE CAD/AI portfolio in the U.S. and Europe, introducing AI-powered computer-aided detection applications designed to support earlier detection of gastrointestinal lesions and enhance endoscopic care pathways. The launch reflects the growing integration of artificial intelligence into endoscopy platforms to improve clinical outcomes and accelerate the adoption of advanced endoscopic operating devices.
Endoscopy Operative Devices Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities across each sub-segment from 2021 to 2033. For this study, Grand View Research has segmented the global endoscopy operative devices market report based on product and region:
Reusable Operative Devices
Disposable Operative Devices
North America
Europe
Asia Pacific
Latin America
Middle East & Africa